Atopic Dermatitis – P20-441

Real world utilization of upadacitinib in adult and adolescent patients living with moderate to severe atopic dermatitis (AD-VISE).

Register Today!

Trial Information

Start DateOctober 2021
Trial Duration~2025
Number of Visits10
Lead CRCAndrea Carruthers

For additional information
on this trial contact:

Phone705-566-0005